Advertisement

Topics

Morgan Stanley downgrades Teva

09:21 EDT 7 Aug 2017 | Globes

Analyst David Risinger's new price target implies a further 20% drop in Teva's share price.

Original Article: Morgan Stanley downgrades Teva

NEXT ARTICLE

More From BioPortfolio on "Morgan Stanley downgrades Teva"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...